Breaking Down SG&A Expenses: argenx SE vs Walgreens Boots Alliance, Inc.

SG&A Expenses: Retail Giant vs. Biotech Innovator

__timestampWalgreens Boots Alliance, Inc.argenx SE
Wednesday, January 1, 2014179920000004241601.57
Thursday, January 1, 2015224000000005392385.38
Friday, January 1, 2016239100000007370036.73
Sunday, January 1, 20172381300000014970357
Monday, January 1, 20182469400000031413266
Tuesday, January 1, 20192355700000072279461
Wednesday, January 1, 202025436000000183907682
Friday, January 1, 202124586000000307644000
Saturday, January 1, 202227295000000472132000
Sunday, January 1, 202334205000000709539000
Monday, January 1, 202428113000000
Loading chart...

Data in motion

A Tale of Two Companies: SG&A Expenses Over Time

In the ever-evolving landscape of global business, understanding the financial health of companies is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two prominent companies: Walgreens Boots Alliance, Inc. and argenx SE, from 2014 to 2023.

Walgreens Boots Alliance, a giant in the retail pharmacy sector, consistently reported SG&A expenses, peaking at approximately $28 billion in 2024. This represents a steady increase of around 59% from 2014. In contrast, argenx SE, a biotechnology firm, showcased a remarkable growth trajectory, with expenses surging from a modest $4 million in 2014 to $709 million in 2023, marking an exponential rise.

This comparison highlights the diverse financial strategies and growth patterns of a retail behemoth versus a burgeoning biotech innovator, offering valuable insights into their operational dynamics.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025